Skip to main content

Advertisement

Log in

Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation

  • Original Paper
  • Published:
Bioprocess and Biosystems Engineering Aims and scope Submit manuscript

Abstract

The morphology of gelatin nanoparticles loaded with three different drugs (Tizanidine hydrochloride, Gatifloxacin and Fluconazole) and their characteristics of entrapment and release from gelatin nanoparticles were investigated by the analysis on nanoparticle size distribution, SEM and FT-IR in this study. The particles were prepared by nanoprecipitation using water and ethanol as a solvent and a nonsolvent, respectively. The exclusion of a crosslinking agent from the procedure led the system to have an irregularly-shaped morphology. Nonetheless, the uncrosslinked case of Gatifloxacin loading generally led to a more homogeneous population of nanoparticles than the uncrosslinked case of Tizanidine hydrochloride loading. No loading was achieved in the case of Fluconazole, whereas both Tizanidine hydrochloride and Gatifloxacin are observed of being capable of being loaded by nanoprecipitation. Tizanidine hydrochloride-loaded, blank and Gatifloxacin-loaded nanoparticles yielded, under crosslinked condition, 59.3, 23.1 and 10.6% of the used dried mass. The crosslinked Tizanidine hydrochloride-loaded particles showed the loading efficiency of 13.8%, which was decreased to 1.1% without crosslinking. A crosslinker such as glutaraldehyde is indispensable to enhance the Tizanidine hydrochloride-loading efficiency. To the contrary, the Gatifloxacin-loading efficiency for crosslinked ones was lower by a factor of 2–3 times than that for uncrosslinked ones. This is due to the carboxylic groups of Gatifloxacin and the aldehyde groups of glutaraldehyde competing with each other during the crosslinking process, to react with the amino groups of gelatin molecules. The loading efficiency of gelatin nanoparticles reported by other investigators greatly varies. Nevertheless, the loading efficiency reported by us is in good agreement with the drug-loading data of gelatin nanoparticles reported by other investigators. The 80% of loaded Tizanidine hydrochloride was released around 15 h after start-up of the release experiment, while the 20% of loaded Gatifloxacin was released more rapidly, as free Gatifloxacin, than the loaded Tizanidine hydrochloride and it showed the trend of sustained slow release during the remaining period of its release experiment. Furthermore, the result of comparative FT-IR analysis is consistent to that of the corresponding drug release study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15

Similar content being viewed by others

References

  1. Mohanraj VJ, Chen Y (2006) Nanoparticles–a review. Trop J Pharm Res 5(1):561–573

    Google Scholar 

  2. Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F (2006) Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed Nanotech Bio Med 2:8–21

    Article  CAS  Google Scholar 

  3. Wade A, Weller PJ (1995) Hand book of pharmaceutical excipients, 2nd edn. Pharmaceutical Press, London, p 199

  4. Coester CJ, Langer K, Briesen HV, Kreuter J (2000) Gelatin nanoparticles by two step desolvation a new preparation method, surface modifications and cell uptake. J Microencapsul 17(2):187–193

    Article  CAS  Google Scholar 

  5. Zwiorek K (2006) Gelatin Nanoparticles as Delivery System for Nucleotide-Based Drugs. PhD Dissertation, Ludwig-Maximilians-University, München

  6. Lu Z, Yeh TK, Tsai M, Au JLS, Wientjes MG (2004) Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Clin Cancer Res 10:7677–7684

    Article  CAS  Google Scholar 

  7. Bilati U, Allemann E, Doelker E (2005) Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 24:67–75

    Article  CAS  Google Scholar 

  8. Guerrero DQ, Allemann E, Fessi H, Doelker E (1998) Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 24(12):1113–1128

    Article  Google Scholar 

  9. Mahadik KR, Paradkar AR, Agrawal H, Kaul N (2003) Stability-indicating HPTLC determination of tizanidine hydrochloride in bulk drug and pharmaceutical formulations. J Pharma Biomed Anal 33:545–552

    Article  CAS  Google Scholar 

  10. Rathore MS, Majumdar DK (2006) Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS Pharm Sci Tech 7(3):57

    Article  Google Scholar 

  11. Venugopal K, Saha RN (2005) New, simple and validated UV spectrophotometric methods for the estimation of gatifloxacin in bulk and formulations. Il Farmaco 60:906–912

    Article  CAS  Google Scholar 

  12. Kaliamurthy J, Nelson Jesudasan CA, Geraldine P, Parmar P, Kalavathy CM, Thomas PA (2005) Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res 37:117–122

    Article  CAS  Google Scholar 

  13. Marciniec B, Dettlaff K, Jaroszkiewicz E, Bafeltowska J (2007) Radiochemical stability of fluconazole in the solid state. J Pharm and Biomed Anal 43:1876–1880

    Article  CAS  Google Scholar 

  14. Cascone MG, Lazzeri L (2002) Gelatin nanoparticles produced by a simple w/o emulsion as delivery system for methotrexate. J Mater Sci 13:523–526

    Article  CAS  Google Scholar 

  15. Bajpai AK, Choubey J (2006) Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med 17:345–358

    Article  CAS  Google Scholar 

  16. Leo E, Cameroni R, Forni F (1999) Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticles conjugates. Int J Pharma 180:23–30

    Article  CAS  Google Scholar 

  17. Vandervoort J, Ludwig A (2004) Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm 57:251–261

    Article  CAS  Google Scholar 

  18. Kaul G, Amiji M (2002) Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 19(2):1061–1067

    Article  CAS  Google Scholar 

  19. Saxena A, Sachin K, Bohindar HB, Verma AK (2005) Effect of molecular weight heterogeneity on drug encapsulation efficiency of gelatin nanoparticles. Colloids Surf B 45:42–48

    Article  CAS  Google Scholar 

  20. Dashora K, Saraf S, Saraf S (2005) Spectrophotometric method for the determination of Tizanidine hydrochloride in solid dosage forms. Orient J Chem 21(3):533–536

    CAS  Google Scholar 

  21. Dashora K, Saraf S, Saraf S (2006) In vitro studies of tizanidine controlled-release microcapsular matrices. Pak J Pharm Sci 19(3):177–181

    CAS  Google Scholar 

  22. Goger NG, Aboul-Enein HY (2001) Quantitative determination of fluconazole in capsules and IV solutions by UV spectrophotometric methods. Anal Lett 34(12):2089–2098

    Article  CAS  Google Scholar 

  23. Tu LS, Dehghani F, Foster NR (2002) Micronisation and microencapsulation of pharmaceuticals using a carbon dioxide antisolvent. Powder Technol 126:134–149

    Article  CAS  Google Scholar 

  24. Liao I-C, Wan ACA, Yim EK, Leong KW (2005) Controlled release from fibers of polyelectrolyte complexes. J Control Release 104:347–358

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported (in part) by the Daegu University Research grant, 2010.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kwang-Hee Lim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, E.J., Khan, S.A., Park, J.K. et al. Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation. Bioprocess Biosyst Eng 35, 297–307 (2012). https://doi.org/10.1007/s00449-011-0591-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00449-011-0591-2

Keywords

Navigation